Equids' Core Vaccines Guidelines in North America: Considerations and Prospective

Overview

Journal Vaccines (Basel)

Date 2022 Mar 26

PMID 35335029

Authors

Helene Desanti-Consoli

Juliette Bouillon

Ronan J J Chapuis

Affiliations

Soon will be listed here.

Abstract

Vaccination against infectious diseases is a cornerstone of veterinary medicine in the prevention of disease transmission, illness severity, and often death in animals. In North American equine medicine, equine vaccines protecting against tetanus, rabies, Eastern and Western equine encephalomyelitis, and West Nile are core vaccines as these have been classified as having a heightened risk of mortality, infectiousness, and endemic status. Some guidelines differ from the label of vaccines, to improve the protection of patients or to decrease the unnecessary administration to reduce potential side effects. In North America, resources for the equine practitioners are available on the American Association of Equine Practitioners (AAEP) website. Conversely, in small companion animals, peer review materials are regularly published in open access journals to guide the vaccination of dogs and cats. The aims of this review are to present how the vaccine guidelines have been established for small companion animals and horses in North America, to review the equine literature to solidify or contrast the current AAEP guidelines of core vaccines, and to suggest future research directions in the equine vaccine field considering small companion animal strategies and the current available resources in equine literature.

Citing Articles

Uveitis and blindness in a closed herd of Equidae following leptospiral infection.

Gerras J, Young K, Roberts D, Waldman G, Salmon J, Gilger B Front Vet Sci. 2025; 11():1504990.

PMID: 39834922 PMC: 11743373. DOI: 10.3389/fvets.2024.1504990.

Vaccination and Control Methods of West Nile Virus Infection in Equids and Humans.

Cendejas P, Goodman A Vaccines (Basel). 2024; 12(5).

PMID: 38793736 PMC: 11125624. DOI: 10.3390/vaccines12050485.

Assessment of tetanus revaccination regimens in horses not vaccinated in the previous year.

Kinoshita Y, Yamanaka T, Kodaira K, Niwa H, Uchida-Fujii E, Ueno T J Vet Med Sci. 2023; 85(7):751-754.

PMID: 37258221 PMC: 10372253. DOI: 10.1292/jvms.23-0158.

An inventory of adjuvants used for vaccination in horses: the past, the present and the future.

Carnet F, Perrin-Cocon L, Paillot R, Lotteau V, Pronost S, Vidalain P Vet Res. 2023; 54(1):18.

PMID: 36864517 PMC: 9983233. DOI: 10.1186/s13567-023-01151-3.

References

Andersen S, Petersen H, Ersboll A, Falk-Ronne J, Jacobsen S . Vaccination elicits a prominent acute phase response in horses. Vet J. 2011; 191(2):199-202. DOI: 10.1016/j.tvjl.2011.01.019. View

Hooker B, Kern J, Geier D, Haley B, Sykes L, King P . Methodological issues and evidence of malfeasance in research purporting to show thimerosal in vaccines is safe. Biomed Res Int. 2014; 2014:247218. PMC: 4065774. DOI: 10.1155/2014/247218. View

Van Galen G, Saegerman C, Rijckaert J, Amory H, Armengou L, Bezdekova B . Retrospective evaluation of 155 adult equids and 21 foals with tetanus in Western, Northern, and Central Europe (2000-2014). Part 1: Description of history and clinical evolution. J Vet Emerg Crit Care (San Antonio). 2017; 27(6):684-696. DOI: 10.1111/vec.12668. View

Feher O, Bakonyi T, Barna M, Nagy A, Takacs M, Szenci O . Serum neutralising antibody titres against a lineage 2 neuroinvasive West Nile Virus strain in response to vaccination with an inactivated lineage 1 vaccine in a European endemic area. Vet Immunol Immunopathol. 2020; 227:110087. DOI: 10.1016/j.vetimm.2020.110087. View

Ford R, Larson L, McClure K, Schultz R, Welborn L . 2017 AAHA Canine Vaccination Guidelines. J Am Anim Hosp Assoc. 2017; 53(5):243-251. DOI: 10.5326/JAAHA-MS-6741. View

Liefman C . Combined active-passive immunisation of horses against tetanus. Aust Vet J. 1980; 56(3):119-22. DOI: 10.1111/j.1751-0813.1980.tb05647.x. View

Harvey A, Watson J, Brault S, Edman J, Moore S, Kass P . Duration of serum antibody response to rabies vaccination in horses. J Am Vet Med Assoc. 2016; 249(4):411-8. DOI: 10.2460/javma.249.4.411. View

WIKTOR T, Doherty P, KOPROWSKI H . In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus. Proc Natl Acad Sci U S A. 1977; 74(1):334-8. PMC: 393254. DOI: 10.1073/pnas.74.1.334. View

McFarlane D . Equine pituitary pars intermedia dysfunction. Vet Clin North Am Equine Pract. 2011; 27(1):93-113. DOI: 10.1016/j.cveq.2010.12.007. View

10.

Muirhead T, McClure J, Wichtel J, Stryhn H, Markham R, McFarlane D . The effect of age on serum antibody titers after rabies and influenza vaccination in healthy horses. J Vet Intern Med. 2008; 22(3):654-61. DOI: 10.1111/j.1939-1676.2008.0091.x. View

11.

Cauchard J, Sevin C, Ballet J, Taouji S . Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine. Vet Microbiol. 2004; 104(1-2):73-81. DOI: 10.1016/j.vetmic.2004.09.006. View

12.

Vest D, Cohen N, Berezowski C, Morehead J, Blodgett G, Blanchard T . Evaluation of administration of West Nile virus vaccine to pregnant broodmares. J Am Vet Med Assoc. 2005; 225(12):1894-7. DOI: 10.2460/javma.2004.225.1894. View

13.

Holmes M, Townsend H, Kohler A, Hussey S, Breathnach C, Barnett C . Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus. Vet Immunol Immunopathol. 2006; 111(1-2):67-80. DOI: 10.1016/j.vetimm.2006.01.010. View

14.

Pusterla N, Collier J, Mapes S, Wattanaphasak S, Gebhart C . Effects of administration of an avirulent live vaccine of Lawsonia intracellularis on mares and foals. Vet Rec. 2009; 164(25):783-5. DOI: 10.1136/vr.164.25.783. View

15.

Lohrer J, Radvila P . [Active tetanus prevention in the horse and the duration of immunity]. Schweiz Arch Tierheilkd. 1970; 112(7):307-14. View

16.

Broaddus C, Balasuriya U, White J, Timoney P, Funk R, Holyoak G . Evaluation of the safety of vaccinating mares against equine viral arteritis during mid or late gestation or during the immediate postpartum period. J Am Vet Med Assoc. 2011; 238(6):741-50. DOI: 10.2460/javma.238.6.741. View

17.

Davis E, Bello N, Bryan A, Hankins K, Wilkerson M . Characterisation of immune responses in healthy foals when a multivalent vaccine protocol was initiated at age 90 or 180 days. Equine Vet J. 2014; 47(6):667-74. DOI: 10.1111/evj.12350. View

18.

Chaintoutis S, Diakakis N, Papanastassopoulou M, Banos G, Dovas C . Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions. Clin Vaccine Immunol. 2015; 22(9):1040-9. PMC: 4550672. DOI: 10.1128/CVI.00302-15. View

19.

Green S, Smith L, Vernau W, Beacock S . Rabies in horses: 21 cases (1970-1990). J Am Vet Med Assoc. 1992; 200(8):1133-7. View

20.

Day M . The CALLISTO Project: A Summary. J Comp Pathol. 2015; 155(1 Suppl 1):S1-7. DOI: 10.1016/j.jcpa.2015.01.005. View